“I suppose,” Kim said, trying to hide her disappointment.
The unloading of the moving van went considerably faster than its loading, and soon the cottage was filled to overflowing with boxes and haphazardly placed furniture. When the truck was empty, the movers picked up their gear and the boxes that had been unpacked and stowed them in the truck. Kim then signed the moving documents and watched the movers drive away.
No sooner had the truck disappeared from view than Kim saw a Mercedes emerge from the trees and speed toward her. She recognized the car. It was Stanton’s. She called up to Edward to tell him that he had company before going to the door and opening it.
“Where’s Edward?” Stanton demanded without so much as a greeting.
“He’s upstairs,” Kim said, pointing over her shoulder.
Stanton pushed past her and yelled for Edward to come down. He stood in the foyer with his hands on his hips, tapping his right foot. He was clearly agitated.
Kim’s pulse quickened. Knowing Edward’s fragile mental state, she was worried that Stanton would set him off. Stanton always operated as if he had no regard for other people’s feelings.
“Come down here, Edward,” Stanton yelled again. “We’ve got to talk.”
Edward appeared at the turn of the stairs. He was descending slowly. “What’s the problem?” he asked.
“Oh, nothing much,” Stanton said sarcastically. “It’s just that your burn-rate on our capital is out of control. This lab of yours is costing an ungodly amount of money. What are you doing, paving the johns with diamonds?”
“What exactly are you referring to?” Edward asked warily.
“The whole thing,” Stanton said. “I’m beginning to think you used to work for the Pentagon, since everything you order is the most expensive available.”
“To do first-class experiments you need a first-class facility,” Edward said. “I made that clear when we talked about forming Omni. I hope you don’t think you can buy such labs at garage sales.”
Kim watched the two men bicker. The longer they argued the less concern she had. Edward was angry but not out of control.
“All right,” Stanton said. “Let’s leave the cost of the lab alone for a moment. Instead I want you to give me a timetable for FDA approval of Ultra. I must know so I can estimate when we might see money coming in instead of going out.”
Edward threw up his hands in exasperation. “We haven’t even opened the doors to the lab and you’re talking about a deadline. We discussed the FDA issue at the restaurant before we agreed to form the company. Have you forgotten?”
“Listen, smartass,” Stanton shot back. “The burden to keep this operation afloat falls on my shoulders. Unfortunately it ain’t going to be an easy task with the rate you are going through our capital.”
Stanton turned to Kim, who was standing against the parlor wall. “Kim,” he said, “tell this thickheaded dork that fiscal responsibility is a prime requirement of startup companies.”
“Leave her out of it!” Edward snarled.
Stanton apparently sensed that he’d pushed Edward too far because he quickly assumed a more conciliatory tone.
“Let’s all be calm,” Stanton said, lifting his hands in supplication. “You have to recognize the reasonableness of my request. I have to have some vague outline of what you are going to do in this gold-plated lab so that I can try to anticipate and provide for our financial needs.”
Edward exhaled noisily and visibly relaxed a degree. “Asking about what we will be doing in the lab is a far different question than bursting in here and demanding a date for FDA approval,” he said.
“I’m sorry I’m not more diplomatic,” Stanton said. “Give me an idea of your plan of attack.”
“As soon as possible we’ll be launching a crash course to learn everything there is to know about Ultra,” Edward said. “First we must complete our knowledge of its basic chemistry, such as its solubility in various solvents, and its reactivity with other compounds. Then we have to commence controlled biological studies to understand metabolism, excretion, and toxicity. The toxicological studies will have to be done in vitro as well as in vivo on individual cells, groups of cells, and intact organisms. We’ll have to start with viruses, then bacteria, and finally higher animals. We’ll have to formulate assays. On a molecular level we’ll have to determine binding sites and methods of action. We’ll have to test under all sorts of conditions of temperature and pH. We’ll have to do all this before we file an investigational new drug application with the FDA, which is what you have to do before you can even start the clinical phase.”
“Good Lord.” Stanton moaned. “You’re making me dizzy. This sounds like decades of work.”
“It’s not decades,” Edward said. “But it is years. I told you that already. At the same time I told you that it would be significantly shorter than the twelve-year average development time for a drug.”
“How about six years?” Stanton questioned.
“I can’t say until we begin work and start getting some data,” Edward said. “All I can say is that it will be more than three years and less than twelve.”
“There’s a chance it could be three years?” Stanton asked hopefully.
“It would be a miracle,” Edward admitted. “But it is possible. But there is another factor you have to consider. The rapid spending of capital has been for the lab, and now that the lab is almost done, spending will drop considerably.”
“I wish I could count on that,” Stanton said. “But I can’t. Soon we will be paying the enormous salaries you promised your Ultra team.”
“Hey, I had to give big salaries to get the best people,” Edward said. “Also, I preferred giving higher salaries rather than more stock. I didn’t want to give away too much equity.”
“The equity isn’t going to be worth anything if we go bankrupt.”
“But we’re ahead of the game,” Edward said. “Most biotech and pharmaceutical companies are formed with no drug on the horizon. We’ve already got the drug.”
“I’m aware of that,” Stanton said. “But I have the jitters. I’ve never invested all my money in one company and then watched it being spent so quickly.”
“You’ve invested it wisely,” Edward said. “We’re both going to be billionaires. Ultra is that good, I’m sure of it. Come on. Let me show you the lab. It will reassure you.”
Kim breathed a sigh of relief as she watched the two men walk toward the lab. Stanton even had his hand draped on Edward’s shoulder.
Once they were gone, Kim surveyed the room. To her surprise her thoughts were not on the ungodly mess the moving had created. Instead the sudden silence brought an intense sense of Elizabeth’s presence and a strong recurrence of her feeling that Elizabeth was trying to communicate with her. But try as she might, Kim could hear no words. Nevertheless, at that moment, Kim was acutely aware that some of Elizabeth existed in the core of her being. And what was now Kim’s home was still in some way Elizabeth’s.
Kim was not entirely comfortable with these thoughts. Somehow she detected an element of distress and urgency in Elizabeth’s message.
Turning her back on what should have been more pressing tasks, Kim hastily unwrapped the newly restored portrait of Elizabeth and hung it over the fireplace. With the repainting of the walls, the portrait’s silhouette had vanished. Kim had to guess how high it had hung. She was following an urge to replace the painting in the exact position it had occupied three hundred years previously.
Kim stepped away and turned to face the mantel. When she did, she was shocked by how lifelike the painting appeared. In better light Kim had thought it was rather primitive. Hanging in the afternoon twilight of the cottage gave a completely different effect. Elizabeth’s green eyes were hauntingly penetrating as they shone through the shadows.